North China Pharmaceutical Company Ltd.
SHH: 600812.SS0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shanghai Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Li Xin Wang
- Employees
- 10,159
- Headquarters
- Shijiazhuang, China
- IPO year
- 1994
- Market cap
- CN¥9.0B
- Website
- https://www.ncpc.cn
Loading 600812…
Loading profile data…Frequently asked questions about 600812
What does North China Pharmaceutical Company Ltd. (600812.SS) do?
North China Pharmaceutical Company Ltd. operates as a chemical pharmaceutical company in China. It primarily offers anti-infective drugs, comprising APIs, and intermediates and their preparations; biotechnology drugs; cardiovascular and immunomodulators; vitamins health consumer products; and bio-agricultural and veterinary drugs. North China Ph...
Where does 600812.SS trade?
North China Pharmaceutical Company Ltd. (600812.SS) trades on the Shanghai Stock Exchange.
What sector is 600812.SS in?
North China Pharmaceutical Company Ltd. (600812.SS) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of North China Pharmaceutical Company Ltd.?
Li Xin Wang is the chief executive officer of North China Pharmaceutical Company Ltd. (600812.SS).
Where is North China Pharmaceutical Company Ltd. headquartered?
North China Pharmaceutical Company Ltd. is headquartered in China.
Does 600812.SS pay a dividend?
Yes — North China Pharmaceutical Company Ltd. (600812.SS) paid a trailing twelve-month dividend of CNY 0.03 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 600812.SS go public?
North China Pharmaceutical Company Ltd. (600812.SS) completed its initial public offering in 1994.